Is Fiasp (insulin aspart, human) covered by Medicare Part D?
5,052 of 5,052 Medicare Part D plan offerings (100%) list Fiasp on their 2026 formulary, most often on tier 3; 27.7% of the formularies that cover it require prior authorization. Part D spending on it was $358 million in 2024 for at least 131,189 people: what plans and patients paid at the pharmacy, before manufacturer rebates (CMS Part D Spending by Drug).
- Plans that cover it
- 100%
- 5,052 of 5,052 offerings; the median drug: 76%
- Usual tier
- Tier 3
- from tier 1 to tier 7
- Prior authorization
- 27.7%
- of formularies that cover it; the median drug: 1%
- Quantity limits
- 33.8%
- of formularies that cover it; the median drug: 30%
0.6% of the formularies that cover it require step therapy (trying another drug first).
Source: CMS Part D formulary file, 2026 second quarter: the formularies in use in 2026. A plan's 2027 formulary can differ; check your own plan's coverage in Medicare Plan Finder.
What does it cost under Part D in 2027?
- A negotiated price
- Medicare negotiated a lower price for Fiasp, in effect from January 1, 2026: $119 for a 30-day supply, against a list price of $495 (2023); CMS gives one figure for NovoLog and Fiasp together. Where your share is a percentage of the drug's price, it is a percentage of the lower price; a flat copay stays as your plan sets it.
- Insulin costs at most $35 a month
- A one-month supply of each Part D-covered insulin costs no more than $35, and the drug deductible does not apply to insulin.
- Your yearly cap in 2027
- Out-of-pocket spending on covered Part D drugs stops at $2,400 in 2027 ($2,100 in 2026); after that, you pay nothing for covered drugs for the rest of the year.
- The deductible
- A plan's drug deductible is at most $700 in 2027 ($615 in 2026); many plans charge less or none.
Source: CMS, Announcement of calendar year 2027 Part D parameters; Medicare.gov, “How much does Medicare drug coverage cost?”; Medicare.gov, “Insulin”; CMS, “Selected drugs and negotiated prices” (read Oct. 7, 2026).
How much does Medicare spend on it?
Part D spending by year
131,189 people filled it under Part D in 2024, in 487,776 claims. The amounts are what plans and patients paid at the pharmacy, before manufacturer rebates.
Source: CMS Medicare Part D Spending by Drug, 2020 to 2024 (published June 2026). Row used: Fiasp (Insulin Aspart (Niacinamide)), Fiasp Flextouch (Insulin Aspart (Niacinamide)), Fiasp Penfill (Insulin Aspart (Niacinamide)).
Which forms and strengths are counted?
- niacinamide 3 ml insulin aspart, human 100 units/ml cartridge
- niacinamide 3 ml insulin aspart, human 100 units/ml pen injector
- niacinamide insulin aspart, human 100 units/ml injectable solution
Which other versions are listed?
The same ingredients under other names, each with its own coverage and spending.
- NovoLog (insulin aspart, human)100% of plan offerings
What else should you check?
- Stand-alone drug plans for 2027Premiums and deductibles
- Drugs Medicare spends the most onThe 2024 spending list
- 2027 costs and limitsDeductibles and out-of-pocket limits
Data, not medical advice. Coverage is the share of plan formularies listing the drug; your plan's formulary, tier and pharmacy decide what you pay.